[go: up one dir, main page]

GB2369299A - Side effects treatment - Google Patents

Side effects treatment

Info

Publication number
GB2369299A
GB2369299A GB0206401A GB0206401A GB2369299A GB 2369299 A GB2369299 A GB 2369299A GB 0206401 A GB0206401 A GB 0206401A GB 0206401 A GB0206401 A GB 0206401A GB 2369299 A GB2369299 A GB 2369299A
Authority
GB
United Kingdom
Prior art keywords
treatment
adjunct
side effects
animals
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0206401A
Other versions
GB0206401D0 (en
Inventor
David Rudov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPQ3050A external-priority patent/AUPQ305099A0/en
Priority claimed from AUPQ4064A external-priority patent/AUPQ406499A0/en
Application filed by Individual filed Critical Individual
Publication of GB0206401D0 publication Critical patent/GB0206401D0/en
Publication of GB2369299A publication Critical patent/GB2369299A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention provides a novel use of a substance comprising a pharmaceutically acceptable liquid extract from a juice derived from cereal plants (which includes wild grasses) and carried in a pharmaceutically acceptable carrier or excipient for application to and take up by an animal subject. The use is for the manufacture of a product for the adjunct treatment of animals including humans, to reduce the incidence or severity of side effects associated with primary chemical treatment of the animal. The invention also provides a product for the adjunct treatment of animals, a process for the adjunct treatment of animals, an adjunct secondary treatment product effective to reduce the incidence or severity of side effects, and a process for enhancing the therapeutic treatment of an animal.
GB0206401A 1999-09-24 2000-09-25 Side effects treatment Withdrawn GB2369299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ3050A AUPQ305099A0 (en) 1999-09-24 1999-09-24 Side effects treatment
AUPQ4064A AUPQ406499A0 (en) 1999-11-16 1999-11-16 Side effects treatment
PCT/AU2000/001159 WO2001022980A1 (en) 1999-09-24 2000-09-25 Side effects treatment

Publications (2)

Publication Number Publication Date
GB0206401D0 GB0206401D0 (en) 2002-05-01
GB2369299A true GB2369299A (en) 2002-05-29

Family

ID=25646155

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0206401A Withdrawn GB2369299A (en) 1999-09-24 2000-09-25 Side effects treatment

Country Status (3)

Country Link
DE (1) DE10085032T1 (en)
GB (1) GB2369299A (en)
WO (1) WO2001022980A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003015804A1 (en) * 2001-08-17 2003-02-27 David Rudov Treatment to improve central nervous system function

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3787591A (en) * 1971-09-16 1974-01-22 Japan Natural Food Co Ltd Process for producing powders of green leaves of wheat and barley
AU8198587A (en) * 1986-12-03 1988-06-09 David Rudov Pharmacological/cosmetic preparation for external application containing cereal plant extract
WO1991011191A1 (en) * 1990-02-05 1991-08-08 David Rudov Pharmacological compositions containing extracts derived from gramineae plant family and uses thereof
EP0620007A1 (en) * 1993-02-16 1994-10-19 SOKEN Co., Ltd. Anti-ulcer agent
CN1098851A (en) * 1993-08-16 1995-02-22 青岛太平洋科技实业公司 Marine alga noodles
WO1995006459A1 (en) * 1993-09-01 1995-03-09 Helsinki University Licensing Ltd. Stable composition containing wheat sprout juice and process for producing it
CN1106227A (en) * 1994-09-02 1995-08-09 沈阳振兴食品厂 Edible mushroom vermicelli and its prepn.
JP2000044459A (en) * 1998-07-29 2000-02-15 Tekunooburu:Kk Skin preparation for external use

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3787591A (en) * 1971-09-16 1974-01-22 Japan Natural Food Co Ltd Process for producing powders of green leaves of wheat and barley
AU8198587A (en) * 1986-12-03 1988-06-09 David Rudov Pharmacological/cosmetic preparation for external application containing cereal plant extract
WO1991011191A1 (en) * 1990-02-05 1991-08-08 David Rudov Pharmacological compositions containing extracts derived from gramineae plant family and uses thereof
EP0620007A1 (en) * 1993-02-16 1994-10-19 SOKEN Co., Ltd. Anti-ulcer agent
CN1098851A (en) * 1993-08-16 1995-02-22 青岛太平洋科技实业公司 Marine alga noodles
WO1995006459A1 (en) * 1993-09-01 1995-03-09 Helsinki University Licensing Ltd. Stable composition containing wheat sprout juice and process for producing it
CN1106227A (en) * 1994-09-02 1995-08-09 沈阳振兴食品厂 Edible mushroom vermicelli and its prepn.
JP2000044459A (en) * 1998-07-29 2000-02-15 Tekunooburu:Kk Skin preparation for external use

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Cancer Biotherapy and Radiopharmaceuticals Vol. 14, No. 4, 1999, pages 277-289 *
Patent Abstract of Japan & JP 2000 044 459 A (TEKUNOOBURU:KK) 15 February 2000 … *
Scandinavian Journal of Gastroenterology Vol. 33, 1998, pages 159-163 *

Also Published As

Publication number Publication date
WO2001022980A1 (en) 2001-04-05
GB0206401D0 (en) 2002-05-01
DE10085032T1 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
Matsunaka Propanil hydrolysis: inhibition in rice plants by insecticides
TNSN07208A1 (en) 3,5-DISUBTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d] PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
GB0225475D0 (en) Therapeutic agents
FR2771291B1 (en) SPHEROIDS, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS
TNSN04113A1 (en) 3-â-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
GB0223038D0 (en) Therapeutic compounds
AU3040995A (en) Treatment of autoimmune diseases by oral administration of autoantigens
MY121548A (en) Compounds and methods for the treatment of cancer
EA200000512A1 (en) MEDICINES, FOOD PRODUCTS AND DRINKS USING PHYIOLOGICALLY ACTIVE SUBSTANCES RECEIVED FROM SEA ALGAE
HUT76511A (en) Benzoyl derivatives, preparation and use thereot
GB0222514D0 (en) Organic compounds
EA200000355A2 (en) INDUSTRIAL PRODUCTS
DE69819110D1 (en) A medicine to treat obesity and improve lipid metabolism
MXPA06014182A (en) 3-beta-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF.
ATE265851T1 (en) TREATMENT OF DISEASES CAUSED BY CYTOKINE GROWTH FACTOR
ATE157871T1 (en) MEDICINAL PRODUCTS FOR THE THERAPEUTIC AND PROPHYLACTIC TREATMENT OF DISEASES CAUSED BY HYPERPLASIA OF SMOOTH MUSCLE CELLS
GB2369299A (en) Side effects treatment
PT1237562E (en) PROCESS OF PREPARATION OF MYCANYAN EXTRACTS CONTAINING MICANOLIDE AND DIHYDROMICANOLID AND USES IN THE TREATMENT OF PROLIFERATIVE DISEASES
WO2002062952A3 (en) Non-cytotoxic pap mutants
HUP9700661A2 (en) Use of alpha-1-adrenoreceptor antagonists for the production of pharmaceuticals for profilacting and treating cancer
DK1140103T3 (en) Ponazuril for the treatment of neurological and abortion-causing diseases caused by Coccidia
ES2180345T3 (en) NEW PROCEDURE FOR THE CREW-CONSERVATION OF PLANTS.
JPS5399314A (en) Therapeutic agent for nephritis
KR102229827B1 (en) Extract of Water Dropwort with organic germanium inhibiting cytotoxicity and providing immune activity
RU2227748C2 (en) Therapeutic agent for treatment of cachexia

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)